Joint Research Agreement with Institut Pasteur Korea

Published by Omphalos Lifesciences on December 19, 2025December 19, 2025

We are pleased to announce a 𝐉𝐨𝐢𝐧𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐀𝐠𝐫𝐞𝐞𝐦𝐞𝐧𝐭 with Institut Pasteur Korea (IPK), a world-leading center for infectious disease research and a state-of-the-art scientific hub within the global Pasteur Network.

IPK is internationally recognized for its advanced research infrastructure, including BSL-3 laboratory capabilities and high-throughput screening platforms that support rigorous infectious disease and therapeutic discovery programs.

Through this agreement, Omphalos will collaborate with IPK on joint research to advance new approaches for building and validating virtual-bacterial models that can support the development of future therapeutic strategies. This partnership brings together Omphalos’ computational modeling technology with IPK’s experimental excellence to accelerate progress in areas of shared scientific interest.

We look forward to working closely with IPK and will share updates as this important collaboration moves forward.

Learn more about Institut Pasteur Korea: https://www.ip-korea.org/
Learn more about Pasteur Network: https://pasteur-network.org/